Bridion 200 MG/2 ML vial 2ML
Ended Awarded
- Contract number
- SPE2DB25FJD95
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,024
Award facts
- Contract value 100% obligated
- $11,023.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $11,023.63 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Bridion 200 mg/2 mL vials. This competitively awarded, firm fixed-price delivery order, which is not set-aside, has an ultimate completion date of July 31, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Bridion is a neuromuscular blocking agent reversal agent used in surgical and anesthetic settings, representing the type of specialized pharmaceutical product critical to military medical operations.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp serves as a prime vendor for the DLA Medical Supply Chain, supplying a comprehensive range of pharmaceuticals, vaccines, medical devices, and specialized healthcare commodities to support Department of Defense and military healthcare systems globally. The company's substantial IDC position demonstrates its capability to fulfill federal medical procurement requirements and support critical military healthcare missions across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FJD95?
SPE2DB25FJD95 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 30, 2025.
How much is contract SPE2DB25FJD95 worth?
The government has obligated $11,024 on SPE2DB25FJD95.
Is contract SPE2DB25FJD95 an order under another contract?
Yes. SPE2DB25FJD95 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJD95 competed?
The extent of competition for SPE2DB25FJD95 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award